Shareholders Equity: The sum of preferred and common equity items.
Anebulo Pharmaceuticals, Inc. (ANEB) had Shareholders Equity of $9.74M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.16M |
|
-- |
|
-- |
|
$2.26M |
|
$-2.26M |
|
$0.10M |
|
$-2.16M |
|
$-2.16M |
|
$-2.16M |
|
$-2.16M |
|
$-2.16M |
|
$-2.16M |
|
$-2.26M |
|
$-2.24M |
|
41.09M |
|
41.09M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$10.54M |
|
-- |
|
$0.17M |
|
$10.70M |
|
$0.96M |
|
-- |
|
-- |
|
$0.96M |
|
$9.74M |
|
$9.74M |
|
|
Shareholders Equity |
$9.74M |
41.09M |
|
| Cash Flow Statement Financials | |
$-1.27M |
|
-- |
|
-- |
|
$11.63M |
|
$10.35M |
|
$-1.27M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.16% |
|
-22.16% |
|
-20.17% |
|
-22.16% |
|
$0.24 |
|
$-0.03 |
|
$-0.03 |
|